Latest Insider Transactions at Taysha Gene Therapies, Inc. (TSHA)
This section provides a real-time view of insider transactions for Taysha Gene Therapies, Inc. (TSHA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Taysha Gene Therapies, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Taysha Gene Therapies, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2024
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
1,333,333
+50.0%
|
$2,666,666
$2.25 P/Share
|
|
May 29
2024
|
Laura Sepp Lorenzino |
BUY
Grant, award, or other acquisition
|
Direct |
49,220
+50.0%
|
-
|
|
May 29
2024
|
Phillip B. Donenberg |
BUY
Grant, award, or other acquisition
|
Direct |
49,220
+23.16%
|
-
|
|
May 29
2024
|
Alison S Long |
BUY
Grant, award, or other acquisition
|
Direct |
49,220
+50.0%
|
-
|
|
May 29
2024
|
John A Stalfort Iii |
BUY
Grant, award, or other acquisition
|
Direct |
49,220
+4.29%
|
-
|
|
Feb 02
2024
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-0.15%
|
$1,288
$1.51 P/Share
|
|
Jan 02
2024
|
Sean P. Nolan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,184,688
+49.98%
|
-
|
|
Jan 02
2024
|
Sukumar Nagendran President and Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
863,617
+49.03%
|
-
|
|
Jan 02
2024
|
Kamran Alam CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
590,413
+41.21%
|
-
|
|
Nov 17
2023
|
Paul B Manning |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.6%
|
$100,000
$1.63 P/Share
|
|
Aug 24
2023
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
33,000
-11.34%
|
$66,000
$2.33 P/Share
|
|
Aug 16
2023
|
Paul B Manning |
BUY
Open market or private purchase
|
Indirect |
16,466,667
+50.0%
|
$0
$0.9 P/Share
|
|
Aug 16
2023
|
Phillip B. Donenberg |
BUY
Open market or private purchase
|
Direct |
111,111
+49.33%
|
$0
$0.9 P/Share
|
|
Aug 16
2023
|
Sean P. Nolan Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
444,444
+22.45%
|
$0
$0.9 P/Share
|
|
Aug 16
2023
|
John A Stalfort Iii |
BUY
Bona fide gift
|
Direct |
50,000
+4.55%
|
-
|
|
Aug 16
2023
|
John A Stalfort Iii |
BUY
Open market or private purchase
|
Direct |
388,889
+28.01%
|
$0
$0.9 P/Share
|
|
Aug 16
2023
|
John A Stalfort Iii |
BUY
Open market or private purchase
|
Indirect |
388,889
+30.54%
|
$0
$0.9 P/Share
|
|
Jul 13
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
5,344
-0.06%
|
$0
$0.7 P/Share
|
|
Jul 12
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
80,528
-0.9%
|
$0
$0.71 P/Share
|
|
Jun 23
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
18,100
-0.2%
|
$0
$0.7 P/Share
|
|
Jun 22
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
10,508
-0.12%
|
$0
$0.7 P/Share
|
|
Jun 21
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
138,962
-1.52%
|
$0
$0.7 P/Share
|
|
Jun 20
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
295,653
-3.14%
|
$0
$0.71 P/Share
|
|
May 31
2023
|
Kamran Alam CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,230
+2.1%
|
-
|
|
May 16
2023
|
Sukumar Nagendran President and Head of R&D |
BUY
Open market or private purchase
|
Direct |
5,000
+12.75%
|
$0
$0.68 P/Share
|
|
Mar 06
2023
|
R.A. Session Ii |
BUY
Other acquisition or disposition
|
Direct |
251,296
+2.6%
|
-
|
|
Feb 02
2023
|
Kamran Alam CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
18,691
+6.16%
|
-
|
|
Oct 31
2022
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
1,500,000
+47.74%
|
$3,000,000
$2.0 P/Share
|
|
Aug 23
2022
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,325
-1.23%
|
$9,975
$3.47 P/Share
|
|
Aug 22
2022
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,717
-3.48%
|
$29,151
$3.5 P/Share
|
|
Aug 19
2022
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,482
-3.95%
|
$34,446
$3.75 P/Share
|
|
Aug 18
2022
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,476
-2.51%
|
$22,428
$3.87 P/Share
|
|
Jul 06
2022
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
8,956
-1.66%
|
$26,868
$3.79 P/Share
|
|
Jul 05
2022
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
3,905
-0.72%
|
$11,715
$3.51 P/Share
|
|
Jul 01
2022
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
23,923
-4.22%
|
$71,769
$3.53 P/Share
|
|
Jun 30
2022
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
13,892
-2.39%
|
$41,676
$3.72 P/Share
|
|
Jun 29
2022
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
12,324
-2.08%
|
$36,972
$3.81 P/Share
|
|
Feb 03
2022
|
Paul B Manning |
BUY
Open market or private purchase
|
Indirect |
26,602
+1.26%
|
$186,214
$7.84 P/Share
|
|
Feb 03
2022
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
50,000
+26.01%
|
$350,000
$7.84 P/Share
|
|
Feb 02
2022
|
Paul B Manning |
BUY
Open market or private purchase
|
Indirect |
67,000
+26.07%
|
$469,000
$7.77 P/Share
|
|
Feb 02
2022
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
58,000
+38.61%
|
$406,000
$7.77 P/Share
|
|
Feb 02
2022
|
Phillip B. Donenberg |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$21,000
$7.78 P/Share
|
|
Feb 02
2022
|
Sukumar Nagendran President and Head of R&D |
BUY
Open market or private purchase
|
Direct |
10,000
+25.49%
|
$80,000
$8.01 P/Share
|
|
Nov 24
2021
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
2,202
+6.05%
|
$28,626
$13.19 P/Share
|
|
Nov 23
2021
|
R.A. Session Ii |
BUY
Open market or private purchase
|
Direct |
42,518
+0.23%
|
$510,216
$12.39 P/Share
|
|
Nov 23
2021
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
20,000
+38.46%
|
$240,000
$12.54 P/Share
|
|
Aug 20
2021
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,840
-1.92%
|
$189,440
$16.92 P/Share
|
|
Aug 19
2021
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,967
-1.56%
|
$159,472
$16.77 P/Share
|
|
Aug 18
2021
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,193
-3.38%
|
$190,281
$17.35 P/Share
|
|
Jul 01
2021
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
19,706
-3.21%
|
$413,826
$21.12 P/Share
|